Persistent lipoprotein(a) exposure and its association with clinical outcomes after acute myocardial infarction: a longitudinal cohort study

Aims To assess the link between persistent lipoprotein(a) [Lp(a)] exposure levels and clinical outcomes in patients with acute myocardial infarction (AMI).Methods This longitudinal cohort study included 1131 AMI patients, categorizing persistent Lp(a) exposure based on measurements at admission and...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhenwei Wang, Junnan Tang, Qian Shi, Lijuan Fang, Naifeng Liu, Jinying Zhang
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Annals of Medicine
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/07853890.2025.2454975
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832542849394016256
author Zhenwei Wang
Junnan Tang
Qian Shi
Lijuan Fang
Naifeng Liu
Jinying Zhang
author_facet Zhenwei Wang
Junnan Tang
Qian Shi
Lijuan Fang
Naifeng Liu
Jinying Zhang
author_sort Zhenwei Wang
collection DOAJ
description Aims To assess the link between persistent lipoprotein(a) [Lp(a)] exposure levels and clinical outcomes in patients with acute myocardial infarction (AMI).Methods This longitudinal cohort study included 1131 AMI patients, categorizing persistent Lp(a) exposure based on measurements at admission and after 1 year. Patients were segmented into four groups using a 300 mg/L Lp(a) threshold: (1) persistent low Lp(a) (lowon admission – lowat 1 year); (2) fortified Lp(a) (lowon admission – highat 1 year); (3) attenuated Lp(a) (highon admission – lowat 1 year); and (4) persistent high Lp(a) (highon admission – highat 1 year). Multivariate Cox regression, subgroup analysis and sensitivity analysis assessed the association between Lp(a) trajectories and major adverse cardiovascular and cerebrovascular events (MACCE), cardiovascular death, non-fatal MI, non-fatal stroke, unplanned revascularization, and all-cause death.Results Over a median 50-month follow-up, 343 (35.70%) patients encountered MACCE, and 210 (18.70%) died, including 126 (11.20%) from cardiovascular causes. The group with persistent high Lp(a) faced increased risk of MACCE (HRadjusted, 1.871; 95% CI: 1.474–2.374), non-fatal stroke (HRadjusted, 1.647; 95% CI: 1.031–2.632), unplanned revascularization (HRadjusted, 1.571; 95% CI: 1.008–2.449), and both all-cause (HRadjusted, 1.546; 95% CI: 1.134–2.108) and cardiovascular death (HRadjusted, 2.163; 95% CI: 1.405–3.331), compared to the persistent low Lp(a) group.Conclusions In AMI patients, sustained high Lp(a) levels were significantly associated with increased risk of MACCE, non-fatal stroke, unplanned revascularization, and both all-cause and cardiovascular death.
format Article
id doaj-art-bcf7aa3ba9ea40fb9b2b66a47373f46c
institution Kabale University
issn 0785-3890
1365-2060
language English
publishDate 2025-12-01
publisher Taylor & Francis Group
record_format Article
series Annals of Medicine
spelling doaj-art-bcf7aa3ba9ea40fb9b2b66a47373f46c2025-02-03T15:41:18ZengTaylor & Francis GroupAnnals of Medicine0785-38901365-20602025-12-0157110.1080/07853890.2025.2454975Persistent lipoprotein(a) exposure and its association with clinical outcomes after acute myocardial infarction: a longitudinal cohort studyZhenwei Wang0Junnan Tang1Qian Shi2Lijuan Fang3Naifeng Liu4Jinying Zhang5Department of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaDepartment of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaNeonatal Intensive Care Unit, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaDepartment of Cardiology, The First Hospital of Hohhot, Hohhot, ChinaDepartment of Cardiology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, ChinaDepartment of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaAims To assess the link between persistent lipoprotein(a) [Lp(a)] exposure levels and clinical outcomes in patients with acute myocardial infarction (AMI).Methods This longitudinal cohort study included 1131 AMI patients, categorizing persistent Lp(a) exposure based on measurements at admission and after 1 year. Patients were segmented into four groups using a 300 mg/L Lp(a) threshold: (1) persistent low Lp(a) (lowon admission – lowat 1 year); (2) fortified Lp(a) (lowon admission – highat 1 year); (3) attenuated Lp(a) (highon admission – lowat 1 year); and (4) persistent high Lp(a) (highon admission – highat 1 year). Multivariate Cox regression, subgroup analysis and sensitivity analysis assessed the association between Lp(a) trajectories and major adverse cardiovascular and cerebrovascular events (MACCE), cardiovascular death, non-fatal MI, non-fatal stroke, unplanned revascularization, and all-cause death.Results Over a median 50-month follow-up, 343 (35.70%) patients encountered MACCE, and 210 (18.70%) died, including 126 (11.20%) from cardiovascular causes. The group with persistent high Lp(a) faced increased risk of MACCE (HRadjusted, 1.871; 95% CI: 1.474–2.374), non-fatal stroke (HRadjusted, 1.647; 95% CI: 1.031–2.632), unplanned revascularization (HRadjusted, 1.571; 95% CI: 1.008–2.449), and both all-cause (HRadjusted, 1.546; 95% CI: 1.134–2.108) and cardiovascular death (HRadjusted, 2.163; 95% CI: 1.405–3.331), compared to the persistent low Lp(a) group.Conclusions In AMI patients, sustained high Lp(a) levels were significantly associated with increased risk of MACCE, non-fatal stroke, unplanned revascularization, and both all-cause and cardiovascular death.https://www.tandfonline.com/doi/10.1080/07853890.2025.2454975Lipoprotein(a)exposureacute myocardial infarctionmajor adverse cardiovascular and cerebrovascular eventscardiovascular death
spellingShingle Zhenwei Wang
Junnan Tang
Qian Shi
Lijuan Fang
Naifeng Liu
Jinying Zhang
Persistent lipoprotein(a) exposure and its association with clinical outcomes after acute myocardial infarction: a longitudinal cohort study
Annals of Medicine
Lipoprotein(a)
exposure
acute myocardial infarction
major adverse cardiovascular and cerebrovascular events
cardiovascular death
title Persistent lipoprotein(a) exposure and its association with clinical outcomes after acute myocardial infarction: a longitudinal cohort study
title_full Persistent lipoprotein(a) exposure and its association with clinical outcomes after acute myocardial infarction: a longitudinal cohort study
title_fullStr Persistent lipoprotein(a) exposure and its association with clinical outcomes after acute myocardial infarction: a longitudinal cohort study
title_full_unstemmed Persistent lipoprotein(a) exposure and its association with clinical outcomes after acute myocardial infarction: a longitudinal cohort study
title_short Persistent lipoprotein(a) exposure and its association with clinical outcomes after acute myocardial infarction: a longitudinal cohort study
title_sort persistent lipoprotein a exposure and its association with clinical outcomes after acute myocardial infarction a longitudinal cohort study
topic Lipoprotein(a)
exposure
acute myocardial infarction
major adverse cardiovascular and cerebrovascular events
cardiovascular death
url https://www.tandfonline.com/doi/10.1080/07853890.2025.2454975
work_keys_str_mv AT zhenweiwang persistentlipoproteinaexposureanditsassociationwithclinicaloutcomesafteracutemyocardialinfarctionalongitudinalcohortstudy
AT junnantang persistentlipoproteinaexposureanditsassociationwithclinicaloutcomesafteracutemyocardialinfarctionalongitudinalcohortstudy
AT qianshi persistentlipoproteinaexposureanditsassociationwithclinicaloutcomesafteracutemyocardialinfarctionalongitudinalcohortstudy
AT lijuanfang persistentlipoproteinaexposureanditsassociationwithclinicaloutcomesafteracutemyocardialinfarctionalongitudinalcohortstudy
AT naifengliu persistentlipoproteinaexposureanditsassociationwithclinicaloutcomesafteracutemyocardialinfarctionalongitudinalcohortstudy
AT jinyingzhang persistentlipoproteinaexposureanditsassociationwithclinicaloutcomesafteracutemyocardialinfarctionalongitudinalcohortstudy